A. Galor, Benjamin Seiden, Jasmine J. Park, W. Feuer, Allison L. McClellan, Elizabeth R. Felix, R. Levitt, C. Sarantopoulos, D M Wallace
{"title":"美国退伍军人干眼症状严重程度与合并症失眠的关系","authors":"A. Galor, Benjamin Seiden, Jasmine J. Park, W. Feuer, Allison L. McClellan, Elizabeth R. Felix, R. Levitt, C. Sarantopoulos, D M Wallace","doi":"10.1097/ICL.0000000000000349","DOIUrl":null,"url":null,"abstract":"Purpose: To investigate the association between dry eye (DE) and insomnia symptom severity. Methods: Cross-sectional study of 187 individuals seen in the Miami Veterans Affairs eye clinic. An evaluation was performed consisting of questionnaires regarding insomnia (insomnia severity index [ISI]) and DE symptoms, including ocular pain, followed by a comprehensive ocular surface examination. Using a two-step cluster analysis based on intensity ratings of ocular pain, the patient population was divided into two groups (high and low ocular pain groups: HOP and LOP). A control group was ascertained at the same time from the same clinic as defined by no symptoms of DE (Dry Eye Questionnaire 5 [DEQ5], <6). The main outcome measure was the frequency of moderate or greater insomnia in the DE groups. Results: The mean age of the study sample was 63 years, and 93% were male. All insomnia complaints were rated higher in the HOP group compared with the LOP and control groups (P<0.0005). Most (61%) individuals in the HOP group experienced insomnia of at least moderate severity (ISI≥15) compared with the LOP (41%) and control groups (18%) (P<0.0005). Black race (odds ratio [OR], 2.7; 95% confidence interval [CI], 1.2–6.0; P=0.02), depression severity (OR, 1.2; 95% CI, 1.1–1.3; P<0.0005), and DE symptom severity (DEQ5; OR, 1.1; 95% CI, 1.01–1.2; P=0.03) were significantly associated with clinical insomnia (ISI≥15) after controlling for potential confounders. Conclusions: After adjusting for demographics and medical comorbidities, we show that DE symptom severity is positively associated with insomnia severity.","PeriodicalId":12216,"journal":{"name":"Eye & Contact Lens: Science & Clinical Practice","volume":"31 1","pages":"S118–S124"},"PeriodicalIF":0.0000,"publicationDate":"2018-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"35","resultStr":"{\"title\":\"The Association of Dry Eye Symptom Severity and Comorbid Insomnia in US Veterans\",\"authors\":\"A. Galor, Benjamin Seiden, Jasmine J. Park, W. Feuer, Allison L. McClellan, Elizabeth R. Felix, R. Levitt, C. Sarantopoulos, D M Wallace\",\"doi\":\"10.1097/ICL.0000000000000349\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Purpose: To investigate the association between dry eye (DE) and insomnia symptom severity. Methods: Cross-sectional study of 187 individuals seen in the Miami Veterans Affairs eye clinic. An evaluation was performed consisting of questionnaires regarding insomnia (insomnia severity index [ISI]) and DE symptoms, including ocular pain, followed by a comprehensive ocular surface examination. Using a two-step cluster analysis based on intensity ratings of ocular pain, the patient population was divided into two groups (high and low ocular pain groups: HOP and LOP). A control group was ascertained at the same time from the same clinic as defined by no symptoms of DE (Dry Eye Questionnaire 5 [DEQ5], <6). The main outcome measure was the frequency of moderate or greater insomnia in the DE groups. Results: The mean age of the study sample was 63 years, and 93% were male. All insomnia complaints were rated higher in the HOP group compared with the LOP and control groups (P<0.0005). Most (61%) individuals in the HOP group experienced insomnia of at least moderate severity (ISI≥15) compared with the LOP (41%) and control groups (18%) (P<0.0005). Black race (odds ratio [OR], 2.7; 95% confidence interval [CI], 1.2–6.0; P=0.02), depression severity (OR, 1.2; 95% CI, 1.1–1.3; P<0.0005), and DE symptom severity (DEQ5; OR, 1.1; 95% CI, 1.01–1.2; P=0.03) were significantly associated with clinical insomnia (ISI≥15) after controlling for potential confounders. Conclusions: After adjusting for demographics and medical comorbidities, we show that DE symptom severity is positively associated with insomnia severity.\",\"PeriodicalId\":12216,\"journal\":{\"name\":\"Eye & Contact Lens: Science & Clinical Practice\",\"volume\":\"31 1\",\"pages\":\"S118–S124\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"35\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Eye & Contact Lens: Science & Clinical Practice\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/ICL.0000000000000349\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Eye & Contact Lens: Science & Clinical Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/ICL.0000000000000349","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The Association of Dry Eye Symptom Severity and Comorbid Insomnia in US Veterans
Purpose: To investigate the association between dry eye (DE) and insomnia symptom severity. Methods: Cross-sectional study of 187 individuals seen in the Miami Veterans Affairs eye clinic. An evaluation was performed consisting of questionnaires regarding insomnia (insomnia severity index [ISI]) and DE symptoms, including ocular pain, followed by a comprehensive ocular surface examination. Using a two-step cluster analysis based on intensity ratings of ocular pain, the patient population was divided into two groups (high and low ocular pain groups: HOP and LOP). A control group was ascertained at the same time from the same clinic as defined by no symptoms of DE (Dry Eye Questionnaire 5 [DEQ5], <6). The main outcome measure was the frequency of moderate or greater insomnia in the DE groups. Results: The mean age of the study sample was 63 years, and 93% were male. All insomnia complaints were rated higher in the HOP group compared with the LOP and control groups (P<0.0005). Most (61%) individuals in the HOP group experienced insomnia of at least moderate severity (ISI≥15) compared with the LOP (41%) and control groups (18%) (P<0.0005). Black race (odds ratio [OR], 2.7; 95% confidence interval [CI], 1.2–6.0; P=0.02), depression severity (OR, 1.2; 95% CI, 1.1–1.3; P<0.0005), and DE symptom severity (DEQ5; OR, 1.1; 95% CI, 1.01–1.2; P=0.03) were significantly associated with clinical insomnia (ISI≥15) after controlling for potential confounders. Conclusions: After adjusting for demographics and medical comorbidities, we show that DE symptom severity is positively associated with insomnia severity.